Britain offers contingency plan to prevent API shortages

06/18/2013 | In-PharmaTechnologist.com

The U.K. Medicines and Healthcare Products Regulatory Agency, concerned about potential shortages when new rules requiring regulator certificates go into effect July 2, has said that it will allow API imports lacking such written confirmation on a case-by-case basis to ensure continued supplies. Imports should still have a valid EU good manufacturing practices certificate, and drug firms will need to have audited the API manufacturing site within the past three years.

View Full Article in:

In-PharmaTechnologist.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Life Sciences Lawyer (3-5 years exp)
Ropes & Gray LLP
Boston, MA; San Francisco, CA; Silicon Valley, CA, MA
Director of Accreditation
Meridian Health Plan
Detroit, MI
Health Services Researcher
AARP
Washington, DC
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC